论文部分内容阅读
胸腺素的免疫学活性测定问题,关系到对产品质量的评价,也关系到临床应用效果的评价与机制的探讨,虽然国内外许多学者开展研究,但至今仍未彻底解决。作者几年来曾应用细胞免疫低下的患者淋巴细胞、猪血T细胞、脐血T细胞等做体外E受体激活试验,特别是后者,已试用于生产实际,作为评价产品的指标,取得一定成效。从理论上推测,患者的T细胞经与胸腺素共同温育后或经过治疗后,必定产生细胞功能的变化,究竟发生什么变化,
The determination of immunological activity of thymosin, related to the evaluation of product quality, but also related to the clinical evaluation of the effectiveness and mechanism of discussion, although many scholars at home and abroad to carry out research, but it has not yet been completely resolved. In recent years, the authors have used in vitro immunosuppressive lymphocytes, porcine blood T cells, umbilical cord blood T cells and other in vitro E receptor activation test, especially the latter, has been tried in the actual production, as a product evaluation index, to obtain certain Effective. It is theoretically speculated that the patient’s T cells co-incubated with thymosin or after treatment, must produce changes in cell function, what happened,